ARLINGTON, VA — The Department of Defense has unveiled a comprehensive hormonal readiness initiative designed to establish testosterone levels as a primary metric for combat effectiveness and strategic deployment decisions.
According to internal briefing materials circulated to regional commands, the Hormonal Operational Readiness Protocol (HORP) will implement mandatory serum testosterone testing across all active personnel, with results to be cross-referenced against existing fitness assessments, weapons certifications, and geopolitical threat models.
“We owe our warriors the absolute best medical care in the world, and this program delivers on that obligation,” stated department leadership in an official video release. The statement did not clarify whether hormonal optimization constitutes medical care or strategic doctrine, nor did it address the distinction between treating endocrine conditions and using hormone levels as a proxy for military capability.
The initiative follows months of internal debate regarding force modernization. Pentagon analysts determined that existing measures—training hours, marksmanship scores, tactical knowledge, psychological resilience—were insufficient predictors of battlefield performance. Testosterone, by contrast, offers a single quantifiable variable that can be monitored, adjusted, and reported to Congress.
Implementation begins in Q3 2026, with baseline testing across all service branches. Personnel falling below target ranges will be enrolled in “hormonal optimization” programs, the specifics of which remain classified pending legal review.
Defense contractors have already begun developing monitoring hardware compatible with existing military information systems.